Table 3. Cross-reactivity of commercial anti-human IgA and IgG reagents used in sandwich ELISA assays.
Anti Human serum #1 | IgA | IgG | ||||||||||
(from DAKO) | 1 | 1.10 | 1∶100 | 1∶1,000 | 1∶10,000 | 1∶100,000 | 1 | 1.10 | 1∶100 | 1∶1,000 | 1∶10,000 | 1∶100,000 |
Anti-IgA | 2,049± | 1,903± | 1,733± | 646± | 154± | 67± | 1,450± | 494± | 133± | 37± | 26± | 29± |
32 | 42 | 48 | 37 | 28 | 20 | 45 | 39 | 22 | 21 | 26 | 24 | |
Anti-IgG | 815± | 304± | 101± | 53± | 23± | 15± | 1,939± | 1,991± | 1,965± | 1,701± | 918± | 420± |
50 | 45 | 25 | 28 | 24 | 21 | 48 | 43 | 37 | 40 | 34 | 47 | |
Anti Human serum #2 | IgA | IgG | ||||||||||
(from Southern Biotech) | 1 | 1.10 | 1∶100 | 1∶1,000 | 1∶10,000 | 1∶100,000 | 1 | 1.10 | 1∶100 | 1∶1,000 | 1∶10,000 | 1∶100,000 |
Anti-IgA | 1,947± | 1,946± | 1,572± | 627± | 164± | 90± | 1,449± | 469± | 120± | 37± | 21± | 33± |
53 | 48 | 46 | 49 | 36 | 20 | 42 | 47 | 35 | 31 | 24 | 27 | |
Anti-IgG | 809± | 301± | 105± | 40± | 20± | 10± | 1,925± | 1,998± | 1,893± | 1,704± | 966± | 467± |
45 | 43 | 38 | 30 | 28 | 27 | 46 | 55 | 51 | 48 | 40 | 32 |
Dilutions: 1∶1 = 4 microg/mL; 1∶10 = 400 ng/mL; 1∶102 = 40 ng/mL; 1∶103 = 4 ng/mL; 1∶104 = 400 pg/mL; 1∶105 = 40 pg/mL. Response variability was also reported in the Table.
Results are expressed in OD values.